Obesity and menstrual disorders |
| |
| Institution: | 1. Gynaecological Division, St. Mary''s Hospital, Manchester University NHS Foundation Trust, Manchester, UK;2. Department of Obstetrics & Gynaecology, Tameside General Hospital, Manchester, UK;1. Federal State Budget Institution of Higher Education, “Omsk State Medical University” of the Russian Ministry of Health, Omsk, Russian Federation;2. Centre for Perinatal and Reproductive Medicine, University of Perugia, Perugia, Italy;3. Wayne State University Medical School and Perinatal Research Branch, NIH-NICHD, Detroit, MI, 48201, USA;4. Department of Anesthesiology and Сritical Care of Moscow Regional M.V. Vladimirsky Moscow`s Regional Research Clinical Institute, Moscow, Russian Federation;5. Center of New Chemical Technologies Boreskov Institute of Catalysis, Omsk, Russian Federation;6. Institute of Perinatology and Pediatrics, Almazov National Medical Research Centre, Saint-Petersburg, Russian Federation;7. PREIS International and European School of Perinatal, Neonatal and Reproductive Medicine, Florence, Italy;8. Department of Obstetrics, Gynecology and Perinatal Medicine of the Clinical Institute of Children''s Health Named After N.F. Filatov, I.M. Sechenov First State Medical University Under Ministry of Health of the Russian Federation, Moscow, Russian Federation;1. Nottingham Centre for Transgender Health, Nottingham, UK;2. School of Medicine, University of Nottingham, Nottingham, UK;3. Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain;1. Fertiliteitscentrum Antwerpen, GZA Ziekenhuizen, Oosterveldlaan 24, 2610 Wilrijk, Belgium;2. Department of Development and Regeneration, University of Leuven, Herestraat 49, 3000 Leuven, Belgium;3. Department of Public Health and Primary Care, KU Leuven, Kapucijnenvoer 35 Blok D - Bus 7001, 3000 Leuven, Belgium;4. Merck, United States;5. Leuven University Fertility Centre, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium;1. Third Department of Obstetrics and Gynecology, University Hospital “ATTIKON”, Medical School of the National and Kapodistrian University of Athens, Greece;2. First Department of Obstetrics and Gynecology, Alexandra Hospital, Medical School of the National and Kapodistrian University of Athens, Greece;3. Department of Obstetrics and Gynecology, Chania General Hospital “St. George”, Greece;1. Department of Obstetrics and Gynecology, Research Institute “Amsterdam Reproduction and Development”, Amsterdam UMC, Location VU Medical Center, Amsterdam, the Netherlands;2. Department of Obstetrics and Gynecology, Amsterdam UMC, Location AMC, Amsterdam, the Netherlands;3. Medical Library, Vrije Universiteit, 1081 HV, Amsterdam, the Netherlands;4. Department of Obstetrics and Gynaecology, Erasmus Medical Center, Rotterdam, the Netherlands |
| |
| Abstract: | Obesity is a growing public health concern and is associated with a range of menstrual disorders, including heavy menstrual bleeding, oligomenorrhea, dysmenorrhea, and endometrial pathology. Investigations may be more logistically challenging in those in the population with obesity, and because of the heightened risk of endometrial malignancy, there should be a low threshold for biopsy to exclude endometrial hyperplasia. Although treatment modalities for women with obesity are broadly similar to those with a normal BMI, additional consideration must be given to the risks associated with estrogen in obesity. Outpatient management of heavy menstrual bleeding is a developing field and outpatient treatment modalities are preferable in the population with obesity to avoid the morbidity associated with anesthetics. |
| |
| Keywords: | Heavy menstrual bleeding Hormones Menstrual disorders Obesity Surgery |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
